1. Home
  2. CTRI vs ADPT Comparison

CTRI vs ADPT Comparison

Compare CTRI & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

HOLD

Current Price

$28.44

Market Cap

2.6B

Sector

N/A

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.59

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRI
ADPT
Founded
1909
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
CTRI
ADPT
Price
$28.44
$18.59
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$26.40
$16.60
AVG Volume (30 Days)
1.1M
1.9M
Earning Date
02-25-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$2,841,255,000.00
$252,754,000.00
Revenue This Year
$10.65
$50.86
Revenue Next Year
$9.36
$0.53
P/E Ratio
$1,124.92
N/A
Revenue Growth
9.89
42.57
52 Week Low
$14.46
$6.26
52 Week High
$28.89
$20.76

Technical Indicators

Market Signals
Indicator
CTRI
ADPT
Relative Strength Index (RSI) 70.51 59.49
Support Level $26.49 $16.55
Resistance Level $28.75 $19.16
Average True Range (ATR) 1.02 1.00
MACD 0.09 0.18
Stochastic Oscillator 87.97 82.08

Price Performance

Historical Comparison
CTRI
ADPT

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. It operates under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: